AI tool aims to end guesswork in depression meds
NCT ID NCT06550037
First seen Nov 17, 2025 · Last updated May 21, 2026 · Updated 19 times
Summary
This study is collecting data from 350 people with major depression to build an AI tool that helps doctors choose the best antidepressant. Researchers are analyzing genetics, gut bacteria, immune markers, and brain activity. The goal is to create a personalized treatment guide, but this study does not test any new drug or therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Università Degli Studi Di Siena
Siena, 53100, Italy
Conditions
Explore the condition pages connected to this study.